Literature DB >> 7475826

Angiotensin receptor antagonists: focus on losartan.

C I Johnston1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7475826     DOI： 10.1016/s0140-6736(95)92411-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  30 in total

1.  Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors.

Authors:  Benjamin Diop-Frimpong; Vikash P Chauhan; Stephen Krane; Yves Boucher; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

2.  The effects of age and gender on the pharmacokinetics of irbesartan.

Authors:  N N Vachharajani; W C Shyu; R A Smith; D S Greene
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

3.  [Therapy of chronic cardiac insufficiency with ACE inhibitors versus AT1 receptor antagonists. Is there a difference?].

Authors:  B Schieffer; H Drexler
Journal:  Herz       Date:  1997-12       Impact factor: 1.443

Review 4.  A risk-benefit assessment of losartan potassium in the treatment of hypertension.

Authors:  L M Burrell
Journal:  Drug Saf       Date:  1997-01       Impact factor: 5.606

Review 5.  Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonists.

Authors:  C Csajka; T Buclin; H R Brunner; J Biollaz
Journal:  Clin Pharmacokinet       Date:  1997-01       Impact factor: 6.447

Review 6.  ACE inhibitors and the kidney. A risk-benefit assessment.

Authors:  G Navis; H J Faber; D de Zeeuw; P E de Jong
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

7.  Pharmacokinetics and haemodynamics of candesartan cilexetil in hypertensive patients on regular haemodialysis.

Authors:  M Pfister; F Schaedeli; F J Frey; D E Uehlinger
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

Review 8.  [The renin-angiotensin system in cardiovascular diseases].

Authors:  C Unterberg; H Kreuzer; A B Buchwald
Journal:  Med Klin (Munich)       Date:  1998-07-15

Review 9.  Drug interactions with angiotensin receptor blockers: a comparison with other antihypertensives.

Authors:  Thomas Unger; Elena Kaschina
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

10.  In vitro and in vivo studies on chitosan beads of losartan Duolite AP143 complex, optimized by using statistical experimental design.

Authors:  Ashwini Madgulkar; Mangesh Bhalekar; Megha Swami
Journal:  AAPS PharmSciTech       Date:  2009-06-03       Impact factor: 3.246
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.